Events, Strategic Solutions, Inc. Updates
Vaccines for COVID-19. Part 2: And We’re Off!
Research Services, Strategic Solutions, Inc. Updates
There are currently over 140 SARS-cov2 vaccine candidates (here’s the full list). Many of those will likely fail at some point due to lack of funding, poor efficacy, or unacceptable side effects but it is hoped that sufficient number will complete phase III trials and...
Strategic Solutions, Inc. Updates
The news that the Omicron strain of SARS-Cov2 has mouse fingerprints all over it probably didn’t rock your world, but it maybe it should. Let’s first explain the mouse part.Wei et al claim that the molecular spectrum of mutations (i.e., the relative frequency of the...
Strategic Solutions, Inc. Updates
I was heartened to finally see a pragmatic guideline come out of the White House and CDC: reducing quarantine from 10 to 5 days. There’s been some pushback from some epidemiologists and unions, but the truth is if we’re ever going to get back to any semblance of...
Strategic Solutions, Inc. Updates
We’ve seen a lot of drama in the past few weeks with the rise of the Omicron strain. Some of it may turn out to be justified. This strain has an interesting lineage (Figure 1) that came from South Africa. South Africa has been a source of other strains that never...
